Traditional (CA-125) and novel features (Doppler, microbubble contrast-enhanced ultrasound, PAI) can be combined with ultrasound findings and subjective clinical examinations in an effort to improve the early detection of ovarian carcinomas. This evidence concerns the gene MUC16 and ovarian carcinoma.